CSF3 and neutropenia: The aim of the present analysis was to focus on the frequency and the timing of occurrence of neutropenia and FN among patients enrolled in the TRIBE and TRIBE2 study, in order to identify characteristics of patients more likely to experience these adverse events, and to describe the use of G-CSF in these study populations.